Receipt of Significant R&D Tax Refund
Filed with ASX · · 1 page · English
pleased to announce it has received a $410,611 research & ABN 84 622 484 397 development (R&D) tax refund for financial year 2019-2020. ASX Code The R&D tax incentive is an Australian government incentive scheme Corporate Directory expenditure. Chief Executive Officer & The receipt of these funds reflects InteliCare’s significant and ongoing Managing Director investment in developing its proprieta
InteliCare Holdings Limited on 6ix
Earlier from InteliCare
- ACT Distribution Partnership with TADACT
- AGM Managing Director Presentation
- B2C eCommerce Portal Launched
- InteliCare Signs New Vic Distribution with Rehab Hire
- Appendix 4E and Financial Report
Later from InteliCare
- Techknow Investor Presentation
- Significant Order from Eremea Home Care Services in NSW
- Five Year Strategic Supply Agreement with Optus
- Health Metrics Launch
- Intelicare Secures $2.5m to Fund Commercialisation Strategy
Follow InteliCare into a list and get an email when it puts out news.
Follow InteliCare